SCHEMBL30289124

SCHEMBL30289124

O=C(O)CN1CCC(NC(=O)OCc2ccccc2)CC1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.64
GAA P10253 1/20 0.64
CTSL P07711 1/20 0.61
CTSB P07858 1/20 0.61
CTSK P43235 1/20 0.61
TSHR P16473 1/20 0.61
EPHX1 P07099 1/20 0.57
DPP4 P27487 6/20 0.56
DPP7 Q9UHL4 6/20 0.56
KCNH2 Q12809 3/20 0.56
TGM2 P21980 2/20 0.54
HSD11B1 P28845 1/20 0.53
F13A1 P00488 1/20 0.52
TGM1 P22735 1/20 0.52
SIGMAR1 Q99720 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
GPR55 Q9Y2T6 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5122686 0.88 TGM2 (0.67) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL30289539 0.87 ALDH1A1 (0.57) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL30289263 0.85 ALDH1A1 (0.61) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL7394267 0.85 TSHR (0.62) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL3948456 0.84 ALDH1A1 (0.85) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL381922 0.84 ALDH1A1 (0.85) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL3948461 0.84 ALDH1A1 (0.85) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL1870932 0.84 ALDH1A1 (0.67) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL13402357 0.84 ALDH1A1 (0.67) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL19021435 0.84 ALDH1A1 (0.60) ALDH1A1GAACTSLCTSBCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4652161-A1 2,4-DIANILINOPYRIMIDINE-BASED AURORA-A KINASE SELECTIVE DEGRADATION INDUCING COMPOUNDS Uppthera, Inc. (KR) 2025-11-26 EP disclosed
EP-4405359-A2 MDM2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-07-31 EP disclosed
WO-2024155112-A1 2,4-DIANILINOPYRIMIDINE-BASED AURORA-A KINASE SELECTIVE DEGRADATION INDUCING COMPOUNDS UPPTHERA, INC. (KR) 2024-07-25 WO disclosed
WO-2023049790-A2 MDM2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-03-30 WO disclosed